Melatonin arrests peroxynitrite-induced tau hyperphosphorylation and the overactivation of protein kinases in rat brain

被引:38
作者
Yin, Jun
Liu, Ying-Hua
Xu, Ya-Fei
Zhang, Yong-Jie
Chen, Jian-Guo
Shu, Bai-Hua
Wang, Jian-Zhi [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Key Lab Neurol Dis Hubei Prov, Dept Pathophysiol, Wuhan 430030, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Nucl Med, Wuhan, Peoples R China
关键词
antioxidant; glycogen synthase kinase-3 beta; melatonin; mitogen activated protein kinase; peroxynitrite; tau; uric acid;
D O I
10.1111/j.1600-079X.2006.00343.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to examine the in vivo effect of melatonin (MEL) on peroxynitrite-induced tau hyperphosphorylation and the involvement of glycogen synthase kinase-3 beta (GSK-3 beta) and mitogen-activated protein kinase (MAPK) families. Melatonin was injected into the right cerebroventricle of the rats 1 hr before the bilateral hippocampal injection of 3-morpholino-sydnonimine chloride (SIN-1), the recognized donor of peroxynitrite. Thereafter, the phosphorylation level of tau and the activity of the kinases were analyzed. The injection of SIN-1 induced hyperphosphorylation of tau at pS396 epitope with a concomitant activation of GSK-3 beta and selective MAPK isoforms including p38 alpha, p38 beta, and p38 delta but not p38 gamma. The effect of peroxynitrite was confirmed using uric acid, a recognized scavenger of peroxynitrite. Preinjection of MEL significantly arrested the peroxynitrite-induced hyperphosphorylation of tau and the activation of GSK-3 beta and MAPKs. Melatonin also ameliorated peroxynitrite-induced oxidative stress. We conclude that MEL can efficiently arrest peroxynitrite-induced tau hyperphosphorylation, and the underlying mechanism may involve scavenging the reactive species and suppressing the activated GSK-3 beta and p38 MAPK family.
引用
收藏
页码:124 / 129
页数:6
相关论文
共 56 条
  • [1] The chemistry of melatonin's interaction with reactive species
    Allegra, M
    Reiter, RJ
    Tan, DX
    Gentile, C
    Tesoriere, L
    Livrea, MA
    [J]. JOURNAL OF PINEAL RESEARCH, 2003, 34 (01) : 1 - 10
  • [2] Peroxynitrite activates mitogen-activated protein kinase (MAPK) via a MEK-independent pathway: a role for protein kinase C
    Bapat, S
    Verkleij, A
    Post, JA
    [J]. FEBS LETTERS, 2001, 499 (1-2) : 21 - 26
  • [3] Inhibitory effects of melatonin on neural lipid peroxidation induced by intracerebroventricularly administered homocysteine
    Baydas, G
    Kutlu, S
    Naziroglu, M
    Canpolat, S
    Sandal, S
    Ozcan, M
    Kelestimur, H
    [J]. JOURNAL OF PINEAL RESEARCH, 2003, 34 (01) : 36 - 39
  • [4] The Raf/MEK inhibitor PD98059 enhances ERK1/2 phosphorylation mediated by peroxynitrite via enforced mitochondrial formation of reactive oxygen species
    Cerioni, L
    Palomba, L
    Cantoni, O
    [J]. FEBS LETTERS, 2003, 547 (1-3) : 92 - 96
  • [5] PHYSICAL AND CHEMICAL PROPERTIES OF PURIFIED TAU FACTOR AND ROLE OF TAU IN MICROTUBULE ASSEMBLY
    CLEVELAND, DW
    HWO, SY
    KIRSCHNER, MW
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1977, 116 (02) : 227 - 247
  • [6] Permeability of pure lipid bilayers to melatonin
    Costa, EJX
    Lopes, RH
    LamyFreund, MT
    [J]. JOURNAL OF PINEAL RESEARCH, 1995, 19 (03) : 123 - 126
  • [7] RETRACTED: Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration(Retracted article.See vol.129,2016)
    El-Remessy, AB
    Bartoli, M
    Platt, DH
    Fulton, D
    Caldwell, RB
    [J]. JOURNAL OF CELL SCIENCE, 2005, 118 (01) : 243 - 252
  • [8] Neurodegenerative disorders with extensive tau pathology: A comparative study and review
    Feany, MB
    Dickson, DW
    [J]. ANNALS OF NEUROLOGY, 1996, 40 (02) : 139 - 148
  • [9] Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease
    Feng, Z
    Qin, C
    Chang, Y
    Zhang, JT
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2006, 40 (01) : 101 - 109
  • [10] Ferrer I., 2005, Current Alzheimer Research, V2, P3, DOI 10.2174/1567205052772713